CSPC Pharmaceutical Group Limited (FRA:CVG)

Market Cap	11.83B +84.7%
Revenue (ttm)	3.14B -13.4%
Net Income	486.22M -21.2%
EPS	0.04 -18.9%
Shares Out	n/a
PE Ratio	24.33
Forward PE	19.21
Dividend	0.03 (2.39%)
Ex-Dividend Date	Oct 17, 2025

Volume	1,000
Average Volume	132
Open	1.120
Previous Close	1.111
Day's Range	1.114 - 1.120
52-Week Range	0.516 - 1.249
Beta	n/a
RSI	58.76
Earnings Date	Mar 19, 2026

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 19,266
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVG

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY